Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption is a research paper published in Science Translational Medicine (2021). On theSindex it has a DataRank of 0.668. It has been cited 85 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.668
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: U01 AI 129825
National Institutes of Health
Grant: U01 AI 065279
National Institutes of Health
Grant: UM1 Al 126620
National Institutes of Health
Grant: P30 AI 045008
National Institutes of Health
Grant: UM1 AI 126619
National Institutes of Health
Grant: UM1 AI100663
Medical Research Council
Grant: MR/K012037
Bill and Melinda Gates Foundation
Grant: OPP1092074
National Institutes of Health
Grant: UM1 AI 144371
National Institutes of Health
Grant: R01 AI 111789
National Institutes of Health
Grant: R01 AI 114266
National Institutes of Health
Grant: T32 AI 007632
NIH Office of the Director
Grant: P30 AI027767
NIAID NIH HHS
Grant: R33 AI133696
Medical Research Council
Grant: MR/K012037/1
NIAID NIH HHS
Grant: UM1 AI126620
NIAID NIH HHS
Grant: P01 AI131251
NIAID NIH HHS
Grant: R01 AI160607
NIAID NIH HHS
Grant: R01 AI162646
NIAID NIH HHS
Grant: R01 AI118549
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-BIO/29266/2017
Deep Drug Discovery and Deployment
National Institutes of Health
Grant: 1U01AI129825-01
3BNC117 and 10-1074 to suppress HIV-1 replication and reduce the reservoir
National Institutes of Health
Grant: 5U01AI065279-05
Antiviral activity of Peg-IFN alpha in chronic HIV-1
National Institutes of Health
Grant: 2T32AI007632-16
Training in HIV pathogenesis
National Institutes of Health
Grant: 3UM1AI144371-06S1
Nonhuman primate studies for development of a prototype HIV vaccine that induces broadly neutralizing antibodies
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals